In the Media: Highlights from Immunology & Microbiology
Our experts from the Dept of Microbiology & Immunology at the Peter Doherty Institute have been at the forefront of breakthrough research, media commentary and COVID-19. Here are some of the latest highlights.
DMI media highlights - October 2023
- Dr Kevin John Selva (first author) and A/Prof Amy Chung (co-senior author) contributed to world-first research published in JCI Insight and Immunology & Cell Biology that examined how antibodies in saliva and tears work together to protect against infections and regulate the immune system. Read More.
- Prof Kanta Subbarao was interviewed by CNN, STATnews and Financial Assets about the recommended removal of a component of many flu vaccines by the World Health Organisation. A family of viruses known as influenza B/Yamagata appear to be driven into extinction in the Covid-19 pandemic and has not been seen since March 2020.
- Prof Christopher McDevitt is leading the research awarded more than AUD$2.6 million from global non-profit CARB-X, to develop a world-first treatment for antibiotic-resistant community-acquired bacterial pneumonia (CABP). Read More.
Media Coverage includes BioWorld, University of Minnesota and Drug Discovery Online.
- Prof Lachlan Coin was interviewed by the Daily Telegraph and Herald Sun about his research developing a diagnostic blood test for potentially deadly viruses.
- Prof Laura Mackay has been awarded the inaugural Association of Australian Medical Research Institutes (AAMRI) Rising Start Award for her pioneering work in immunology. Read More.
- Research Fellow Stefano Giulieri, first author of a study published in Cell Reports was interviewed by Lab+Life Scientist about the new genetic insights uncovered into Staphylococcus aureus.
- Dr Michelle Wille was part of a HKUMED research team published in Nature, that identified major shifts in the ecology and evolution of highly pathogenic avian influenza H5 viruses.
- Prof Roy Robins-Browne was one of seven global experts providing his opinion on the future of effective antibiotics for The Conversation.
- Prof Lachlan Coin is the laboratory head for the game-changing research in using molecular clues to pinpoint the cause of illness in paediatric healthcare. Read More
- Dr Ash Porter's published a paper on 'The importance of utilizing travel history metadata for informative phylogeographical inferences: a case study of early SARS-CoV-2 introductions into Australia' first published in the Microbiology Society. Read More